|Epimedium × versicolor|
Epimedium, also known as barrenwort, bishop's hat, fairy wings, horny goat weed, or yin yang huo (Chinese: 淫羊藿), is a genus of flowering plants in the family Berberidaceae. The majority of the species are endemic to China, with smaller numbers elsewhere in Asia, and a few in the Mediterranean region.
Species of Epimedium are herbaceous perennials, growing from an underground rhizome. Their growth habits are somewhat variable. Some have solitary stems, others have a "tufted" habit, with multiple stems growing close together. There may be several leaves to a stem or the leaves may be solitary, produced from the base of the plant. Individual leaves are generally compound, often with three leaflets, but also with more. Leaflets usually have spiny margins. The leaves may be annual, making the plant deciduous, or longer lasting, so that the plant is evergreen. The inflorescence is an open raceme or panicle, the number of flowers varying by species.
Individual flowers have parts in fours. There are four smaller outer sepals, usually greenish and shed when the flower opens. Moving inwards, these are followed by four larger petal-like inner sepals, often brightly coloured. Inside the sepals are four true petals. These may be small and flat, but often have a complex shape including a nectar-producing "spur" that may be longer than the sepals. There are four stamens.
One of the common names for the genus, bishop's hat, arises from the shape of the flowers, particularly where the spurs are longer than the sepals.
The genus was given its name by Carl Linnaeus in 1753, along with the European species E. alpinum. The name is derived from a Greek word for a different plant, epimedion. The meaning of the original name is unclear.
- accepted species
- Epimedium acuminatum
- Epimedium alpinum
- Epimedium baiealiguizhouense
- Epimedium baojingensis
- Epimedium borealiguizhouense
- Epimedium brachyrrhizum
- Epimedium brevicornum
- Epimedium campanulatum
- Epimedium chlorandrum
- Epimedium circinatocucullatum
- Epimedium coactum
- Epimedium davidii
- Epimedium dewuense
- Epimedium diphyllum
- Epimedium dolichostemon
- Epimedium ecalcaratum
- Epimedium elatum
- Epimedium elongatum
- Epimedium enshiense
- Epimedium epsteinii
- Epimedium fangii
- Epimedium fargesii
- Epimedium flavum
- Epimedium franchetii
- Epimedium glandulosopilosum
- Epimedium grandiflorum
- Epimedium hunanense
- Epimedium ilicifolium
- Epimedium jingzhouense
- Epimedium koreanum
- Epimedium latisepalum
- Epimedium leptorrhizum
- Epimedium lishihchenii
- Epimedium lobophyllum
- Epimedium macrosepalum
- Epimedium membranaceum
- Epimedium mikinorii
- Epimedium multiflorum
- Epimedium myrianthum
- Epimedium ogisui
- Epimedium parvifolium
- Epimedium pauciflorum
- Epimedium perralderianum
- Epimedium pinnatum
- Epimedium platypetalum
- Epimedium pinnatum
- Epimedium pseudowushanense
- Epimedium pubescens
- Epimedium pubigerum
- Epimedium pudingense
- Epimedium qingchengshanense
- Epimedium reticulatum
- Epimedium rhizomatosum
- Epimedium sagittatum
- Epimedium sempervirens
- Epimedium setosum
- Epimedium shennongjiaensis
- Epimedium shuichengense
- Epimedium stellulatum
- Epimedium sutchuenense
- Epimedium trifoliolatobinatum
- Epimedium truncatum
- Epimedium wushanense
- Epimedium zhushanense
Some artificial hybrids are cultivated in gardens. These include:
- E. × cantabrigiense Stearn, hybrid between E. alpinum and E. pubigerum
- E. × perralchicum Stearn, hybrid between E. perralderianum and E. pinnatum subsp. colchicum
- E. × rubrum Morr., hybrid between E. alpinum and E. grandiflorum
- E. × versicolor Morr., hybrid between E. grandiflorum and E. pinnatum subsp. colchicum
- E. × warleyense Stearn, hybrid between E. alpinum and E. pinnatum subsp. colchicum
- E. × youngianum Fisch & C.A.Mey, hybrid between E. diphyllum and E. grandiflorum
|This section does not cite any sources. (May 2013) (Learn how and when to remove this template message)|
Some varieties and hybrids have been in western cultivation for the last 100 to 150 years. There is now a wide array of new Chinese species being cultivated in the west, many of which have only recently been discovered, and some of which have yet to be named. There are also many older Japanese hybrids and forms, extending the boundaries of the genus in cultivation. Few genera of plants have seen such a dramatic increase in newly discovered species, primarily thanks to the work of Mikinori Ogisu of Japan and Darrell Probst of Massachusetts. The majority of the Chinese species have not been fully tested for hardiness nor indeed for any other aspect of their culture. The initial assumption that the plants would only thrive where their native conditions could be closely replicated have proven to be overly cautious, as most varieties are proving extraordinarily amenable to general garden and container cultivation.
While they can be successfully propagated in early spring, epimediums are best divided in late summer, with the aim of promoting rapid re-growth of roots and shoots before the onset of winter. Several breeders (in particular Darrell Probst, Tim Branney & Robin White) have also undertaken their own hybridization programmes with the genus. Various new nursery selections are gradually appearing in the horticulture trade, the best of which are extending the colour and shape range of the flowers available to the gardener.
Hugely popular as garden plants for centuries in Japan, epimediums are only just beginning to garner attention in the West. While they vary somewhat in their respective hardiness, all are essentially dwellers of the forest floor, and, as such, all require fundamentally similar conditions of moist, free-draining, humus-rich soil and cool shade, with some shelter for the newly emerging leaves. Some of the more robust varieties are often recommended as plants for dry shade, and whilst their tough foliage and stout rhizomes can allow them to grow successfully in such conditions, (and in more open, exposed positions too, in some instances) they will certainly not give their best. Furthermore, dryness and exposure will pretty much guarantee the early death of many of the newer and more delicate species.
Given suitable conditions most epimediums will form beautiful groundcover plants, often with magnificent new leaves tinted in bronze, copper and reds combining with a huge variety of flower colours and forms in spring. Handsome and dense-growing foliage remains present for much of the year, with the leaves often turning purple, crimson and scarlet in autumn in some forms, and remaining evergreen in others. With all varieties, however, the foliage is best cut off at ground level shortly before new leaves emerge, so as to fully reveal their beauty of form and colour. Ideally, a mulch should then be applied to protect the new growth from frosts.
||This section needs more medical references for verification or relies too heavily on primary sources. (September 2012)|
It is sold as a health supplement, usually in raw herb, tablet, or capsule form and sometimes blended with other supplements. The over-exploitation of wild populations of Epimedium for use in traditional Chinese medicine is having potentially serious consequences for the long-term survival of several species, none of which is widely cultivated for medicinal purposes.
Icariin is purported to work by increasing levels of nitric oxide, which relax smooth muscle. It has been demonstrated to relax rabbit penile tissue by nitric oxide and PDE-5 activity. Other research has demonstrated that injections of Epimedium extract directly into the penis of the rat results in an increase in penile blood pressure.
Like sildenafil (the erectile dysfunction drug commonly sold as Viagra), icariin, the active compound in epimedium, inhibits the activity of PDE-5. In vitro assays have demonstrated that icariin weakly inhibits PDE-5 with an IC50 of around 1 μM, while sildenafil has an IC50 of about 6.6 nM (.0066 μM) and vardenafil (Levitra) has an IC50 of about 0.7 nM (.0007 μM). Measured differently, the EC50 of icariin is approximately 4.62 μM, while sildenafil's is .42 μM. With the weak potency of epimedium, and its unknown oral bioavailability, whether orally administered epidemium extract has any effect is unclear from the literature.
A published Italian study modified icariin structurally and investigated a number of derivatives. Inhibitory concentrations for PDE-5 close to sildenafil could be reached. Moreover, the most potent PDE-5 inhibitor of this series was also found to be a less potent inhibitor of phosphodiesterase-6 (PDE-6) and cyclic adenosine monophosphate-phosphodiesterase (cAMP-PDE), thus showing it to have more specificity for PDE-5 than sildenafil.
Epimedium has been shown to up-regulate genes associated with nitric oxide production and changes in adenosine/guanine monophosphate balance in ways that other PDE5 inhibitors do not.
Epimedium was used in a patent infringement case to rescind parts of the U.S. Viagra patent based on historic use in Chinese medicine. The specific claim was that Viagra was the first medical example of a PDE5 inhibitor which treated erectile dysfunction and therefore claimed patent protection from all similar PDE5 inhibitors. Patent examiners used epimedium as an example of prior use and rescinded those portions of the patent, however, the Viagra patent still protects the manufacturing process or chemical formula for sildenafil.
Epimedium wushanense contains a number of flavanoids. 37 compounds were characterized from the underground and aerial parts of the plant. Among them, 28 compounds were prenylflavonoids. The predominant flavonoid, epimedin C, ranged from 1.4 to 5.1% in aerial parts and 1.0 to 2.8% in underground parts.
- Stearn, W. T. The Genus Epimedium, revised edition 2002. ISBN 0-88192-543-8
- Avent, T. An Overview of Epimedium. The Plantsman. March, 2010.
|Wikimedia Commons has media related to Epimedium.|
- "IPNI Plant Name Query Results for Epimedium". The International Plant Names Index. Retrieved 2013-05-11.
- Epimedium. Flora of China.
- Ying, Junsheng; Boufford, David E. & Brach, Anthony R. (1994 onwards). "Epimedium". In Wu, Zhengyi; Raven, Peter H. & Hong, Deyuan. Flora of China (online). eFloras.org. Retrieved 2013-05-11. Check date values in:
- Linnaeus, Carl von. 1753. Species Plantarum 1: 117 in Latin
- Johnson, A.T. & Smith, H.A. (1972). Plant Names Simplified : Their Pronunciation Derivation & Meaning. Buckenhill, Herefordshire: Landsmans Bookshop. ISBN 978-0-900513-04-6.
- Beckett, K., ed. (1993). "Epimedium". Encyclopaedia of Alpines : Volume 1 (A–K). Pershore, UK: AGS Publications. ISBN 978-0-900048-61-6. pp. 437–441.
- PubChem Entry for Icariin.
- Chiu, JH; Chen, KK; Chien, TM; et al. (2006). "Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway". Int J Impot Res. 18 (4): 335–42. doi:10.1038/sj.ijir.3901437. PMID 16395327.
- Chen, KK; Chiu, JH (2006). "Effect of Epimedium brevicornum Maxim extract on elicitation of penile erection in the rat.". Urology. 67 (3): 631–5. doi:10.1016/j.urology.2005.09.051. PMID 16527595.
- Ning, H; Xin, ZC; Lin, G; et al. (2006). "Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells.". Urology. 68 (6): 1350–4. doi:10.1016/j.urology.2006.09.031. PMID 17169663.
- Xin, ZC; Kim, EK; Lin, CS; et al. (2003). "Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities.". Asian J Androl. 5 (1): 15–8. PMID 12646997.
- Saenz; de Tejada, I; Angulo, J; Cuevas, P; et al. (2001). "The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.". Int J Impot Res. 13 (5): 282–90. doi:10.1038/sj.ijir.3900726. PMID 11890515.
- Jiang, Z; Hu, B; Wang, J; et al. (2006). "Effect of icariin on cyclic GMP levels and on the mRNA expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in penile cavernosum.". J Huazhong Univ Sci Technology Med Sci. 26 (4): 460–2. doi:10.1007/s11596-006-0421-y. PMID 17120748.
- Dell'Agli, M; Galli, GV; Dal Cero, E; et al. (2008). "Potent Inhibition of Human Phosphodiesterase-5 by Icariin Derivatives". J Nat Prod. 71 (9): 1513–7. doi:10.1021/np800049y. PMID 18778098.
- Board of Patent Appeals Affirms Rejection of Pfizer’s Broad Patent over ED Treatment
- Yin XX, Chen ZQ, Liu ZJ, Ma QJ, Dang GT (February 2007). "Icariine stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein 2". Chin. Med. J. 120 (3): 204–10. PMID 17355822.
- Zhang G, Qin L, Shi Y (July 2007). "Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial". J. Bone Miner. Res. 22 (7): 1072–9. doi:10.1359/jbmr.070405. PMID 17419678.
- Chen KM, Ge BF, Liu XY, et al. (May 2007). "Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture". Pharmazie. 62 (5): 388–91. PMID 17557750.
- Huang J, Yuan L, Wang X, Zhang TL, Wang K (August 2007). "Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro". Life Sci. 81 (10): 832–40. doi:10.1016/j.lfs.2007.07.015. PMID 17764702.
- Zhang DW, Cheng Y, Wang NL, Zhang JC, Yang MS, Yao XS (January 2008). "Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts". Phytomedicine. 15 (1-2): 55–61. doi:10.1016/j.phymed.2007.04.002. PMID 17482445.
- Qin L, Han T, Zhang Q, et al. (July 2008). "Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula". J Ethnopharmacol. 118 (2): 271–9. doi:10.1016/j.jep.2008.04.009. PMID 18501540.
- epimedin C
- Li HF, Guan XY, Ye M, Xiang C, Lin CH, Sun C, Guo DA.,"Qualitative and quantitative analyses of Epimedium wushanense by high-performance liquid chromatography coupled with diode array detection and electrospray ionization tandem mass spectrometry." J Sep Sci. 2011 May 10;